Multiple Sclerosis and Depression: Translation and Adaptation of the Spanish Version of the Chicago Multiscale Depression Inventory and the Study of Factors Associated with Depressive Symptoms
Impact
Scholar |
Other documents of the author: Sanchis-Segura, Carla; Cruz Gómez, Álvaro Javier; Félix Esbrí, Sónia; Sebastián Tirado, Alba; Arnett, Peter A; Forn, Cristina
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/8033
comunitat-uji-handle3:10234/8636
comunitat-uji-handle4:
INVESTIGACIONMetadata
Title
Multiple Sclerosis and Depression: Translation and Adaptation of the Spanish Version of the Chicago Multiscale Depression Inventory and the Study of Factors Associated with Depressive SymptomsAuthor (s)
Date
2022-12-08Publisher
Oxford University PressISSN
0887-6177; 1873-5843Bibliographic citation
Carla Sanchis-Segura, Álvaro Javier Cruz-Gómez, Sónia Félix Esbrí, Alba Sebastián Tirado, Peter A Arnett, Cristina Forn, Multiple Sclerosis and Depression: Translation and Adaptation of the Spanish Version of the Chicago Multiscale Depression Inventory and the Study of Factors Associated with Depressive Symptoms, Archives of Clinical Neuropsychology, 2022, acac096, https://doi.org/10.1093/arclin/acac096Type
info:eu-repo/semantics/articlePublisher version
https://academic.oup.com/acn/advance-article/doi/10.1093/arclin/acac096/6883987? ...Version
info:eu-repo/semantics/publishedVersionSubject
Abstract
Objective:
Depressive disorder occurs in up to 50% of persons with Multiple Sclerosis (PwMS). Accurate assessment of depression in MS is essential in clinical settings because depressive symptomatology can affect ... [+]
Objective:
Depressive disorder occurs in up to 50% of persons with Multiple Sclerosis (PwMS). Accurate assessment of depression in MS is essential in clinical settings because depressive symptomatology can affect the clinical course of the disease.
Methods:
We translated, adapted, and tested the Spanish version of the Chicago Multiscale Depression Inventory (CMDI), a specific test to assess depression in neurological disorders. We compare our results with those obtained with previous versions of the questionnaire (English and Italian). Finally, we also analyze the relationship between the results obtained on the CMDI and demographic, clinical, and cognitive variables.
Results:
The results obtained with the Spanish version of the CMDI were similar to those observed in previous published versions. We also observed higher depression scores in PwMS (especially in progressive forms) compared with healthy controls. Moreover, depression symptomatology was related to higher disability and fatigue and worse cognitive performance in PwMS.
Conclusions:
The results support the validity of the CDMI in the Spanish population, as well as the association between depression and other characteristic symptoms of MS. These findings also emphasize the importance of good assessment and multidisciplinary treatment of depression in PwMS. [-]
Is part of
Archives of Clinical Neuropsychology, 2022Funder Name
Universitat Jaume I
Project code
UJI-B2020-02 | PREDOC/2020/22
Rights
info:eu-repo/semantics/openAccess
This item appears in the folowing collection(s)
- PSB_Articles [1310]